EXECUTIVE SUMMARY
Exhibit ES-1: Vascular stents global market forecast, 2016-21
Exhibit ES-2: Global vascular stents market, share by country/region, 2016
Exhibit ES-3: Drivers and limiters of growth of the vascular stents market
CARDIOVASCULAR DISEASES OVERVIEW
Acute coronary syndrome
Atherosclerosis
Angina pectoris
Myocardial infarction
Diagnosis and treatment
Hypertension
Peripheral vascular disease
Critical limb ischemia
Aneurysm
Deep vein thrombosis/pulmonary embolism
Diagnosis and treatment
Cerebrovascular disease
Diagnosis and treatment
Bibliography
Exhibit 1-1: Estimated mortality due to ischemic heart disease and cerebrovascular disease, select countries
Exhibit 1-2: Top 10 countries with the highest CVD death rates
Exhibit 1-3: Estimated incident cases for acute coronary syndrome, select countries
Exhibit 1-4: Age-standardized incidence (000s) of angina pectoris, select regions
Exhibit 1-5: Clinical classification of acute myocardial infarction
Exhibit 1-6: Age-standardized incidence (000s) of acute myocardial infarction, sele
Exhibit 1-7: Estimated incident cases of myocardial infarction, select countries
Exhibit 1-8: Estimated prevalent cases of hypertension, select countries
Exhibit 1-9: Mortality attributable to hypertensive diseases, select countries
Exhibit 1-10: Estimated incident cases of DVT, select countries
Exhibit 1-11: Estimated incident cases of PE, select countries
Exhibit 1-12: Estimated incident cases of stroke, select countries
Exhibit 1-13: Estimated prevalent cases of stroke, select countries
VASCULAR STENT PRODUCTS
Vascular stent products
Vascular stents in development
Trends in vascular stent innovation
Alternatives to vascular stent implantation
Bibliography
Exhibit 2-1: Advantages and disadvantages of stenting
Exhibit 2-2: Images of select vascular stents
Exhibit 2-3: Selected bare-metal stents and manufacturers
Exhibit 2-4: Selected drug-eluting stents and manufacturers
Exhibit 2-5: Advantages and disadvantages of BVSs
Exhibit 2-6: Selected BVSs and manufacturers
Exhibit 2-7: Current clinical trials investigating stent devices
Exhibit 2-8: Selected drug-eluting BVSs in development
Exhibit 2-9: Information on selected non-drug-eluting BVSs in development
. VASCULAR STENTS MARKET
.1 Global market insights
.1.1 Market value
.1.2 Technology trends
.1.3 Market drivers and limiters
.1.4 Vascular stents overview
.1.5 Market leaders
.1.6 Competitive strategies
.1.7 Emerging competition
.2 Global competitors
.2.1 Bare-metal stents
.2.2 Drug-eluting stents
.3 Market forecast
.3.1 Market forecast: US
.3.2 Market forecast: five major EU markets
.3.3 Market forecast: Japan
.3.4 Market forecast: rest of the world
.4 Bibliography
Exhibit 3-1: Vascular stents, global market forecast, 2016-21
Exhibit 3-2: Vascular stent sales combined market forecast, by product segment ($m), 2016-21
Exhibit 3-3: Global vascular stents market, share by country/region, 2016
Exhibit 3-4: Global vascular stent sales combined market forecast, by country/region ($m), 2016-21
Exhibit 3-5: Drivers and limiters of growth of the vascular stents market
Exhibit 3-6: Average sale prices of vascular stents in 2017
Exhibit 3-7: Global bare-metal stents market, share by supplier, 2016
Exhibit 3-8: Global drug-eluting stents market, share by supplier, 2016
Exhibit 3-9: US vascular stent implantation, procedure volumes forecast (000s), 2016-21
Exhibit 3-10: US vascular stent sales combined market forecast, by product segment ($m), 2016-21
Exhibit 3-11: US bare-metal stents market forecast, by type ($m), 2016-21
Exhibit 3-12: US bare-metal stents market, share by supplier, 2016
Exhibit 3-13: US drug-eluting stents market forecast, by type ($m), 2016-21
Exhibit 3-14: US drug-eluting stents market, share by supplier, 2016
Exhibit 3-15: 5EU coronary vascular stent implantation, procedure volumes forecast, by country (000s), 2016-21
Exhibit 3-16: 5EU peripheral vascular stent implantation, procedure volumes forecast, by country (000s), 2016-21
Exhibit 3-17: 5EU vascular stent sales combined market forecast, by product segment ($m), 2016-21
Exhibit 3-18: 5EU bare-metal stents market forecast, by type ($m), 2016-21
Exhibit 3-19: 5EU bare-metal stents market, share by supplier, 2016
Exhibit 3-20: 5EU drug-eluting stents market forecast, by type ($m), 2016-21
Exhibit 3-21: 5EU drug-eluting stents market, share by supplier, 2016
Exhibit 3-22: Japan vascular stent sales combined market forecast, by product segment ($m), 2016-21
Exhibit 3-23: Japan coronary stent implantation, procedure volumes forecast (000s), 2016-21
Exhibit 3-24: Japan bare-metal stents market forecast, by type ($m), 2016-21
Exhibit 3-25: Japan bare-metal stents market, share by supplier, 2016
Exhibit 3-26: Japan drug-eluting stents market forecast, by type ($m), 2016-21
Exhibit 3-27: Japan drug-eluting stents market, share by supplier, 2016
Exhibit 3-28: RoW vascular stent sales combined market forecast, by product segment ($m), 2016-21
Exhibit 3-29: RoW bare-metal stents market forecast, by type ($m) 2016-21
Exhibit 3-30: RoW bare-metal stents market, share by supplier, 2016
Exhibit 3-31: RoW drug-eluting stents market forecast, by type ($m), 2016-21
Exhibit 3-32: RoW drug-eluting stents market, share by supplier, 2016
